Effect of l-carnitine supplementation on lead acetate-induced liver cell apoptosis and inflammation: role of caspase-3 and glycogen synthase kinase-3β enzymes

Life Sci. 2022 Feb 15:291:120277. doi: 10.1016/j.lfs.2021.120277. Epub 2021 Dec 31.

Abstract

Aim: The study aimed at studying the hepatoprotective effect of l-carnitine against lead (Pb) acetate-induced hepatocellular injury, emphasizing the role of caspase-3 and glycogen synthase kinase-3β in hepatocellular apoptosis and inflammation.

Materials and methods: Male Wistar rats were used. The experimental approach involved estimation of the liver enzymes' serum levels. Oxidative and inflammatory biomarkers were measured in hepatic tissue homogenates. Paraffin-embedded hepatic sections were prepared for histopathology and immunohistochemistry. Quantitative determination of the phosphorylated glycogen synthase kinase-3 beta was performed.

Key findings: The serum showed a significant elevation in ALT, AST, and LDH; tissue homogenates showed significant elevation in lipid peroxide and inflammatory biomarkers with significant reduction in reduced glutathione in the Pb acetate-treated group. Co-administration of l-carnitine with Pb acetate produced significant reduction in liver enzymes with significant improvement in oxidant, antioxidant and inflammatory markers. Lead acetate treatment significantly reduced the phosphorylated glycogen synthase kinase-3 beta, while l-carnitine enhanced its phosphorylation. Histopathological examination showed inflammatory reaction around blood vessels with fatty degeneration in hepatocytes of the Pb acetate intoxicated group. l-Carnitine caused a decrease in hepatic damage with minimal vascular alterations in central vein. Caspase-3 expression in hepatocytes was decreased in Pb-treated group supplemented with l-carnitine.

Significance: Our study reveals that oxidative stress and inflammation participate in Pb acetate-induced hepatocellular injury. Glycogen synthase kinase-3β and caspase-3 play role in Pb acetate-induced hepatic damage. l-Carnitine shows significant protective effects against hepatocellular apoptosis and inflammation induced by Pb acetate through antioxidant, anti-inflammatory and anti-apoptotic pathways in part mediated by GSK-3β inhibition.

Keywords: Caspase-3; GSK-3β; Hepatic apoptosis; Immunohistochemistry; Lead acetate; l-Carnitine.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Antioxidants / pharmacology
  • Apoptosis / drug effects
  • Carnitine / metabolism
  • Carnitine / pharmacology*
  • Caspase 3 / metabolism*
  • Caspase 3 / physiology
  • Dietary Supplements
  • Glycogen Synthase Kinase 3 beta / metabolism*
  • Glycogen Synthase Kinase 3 beta / physiology
  • Hepatocytes / drug effects
  • Hepatocytes / metabolism
  • Inflammation / metabolism
  • Liver / drug effects
  • Liver / pathology
  • Male
  • Organometallic Compounds / adverse effects
  • Organometallic Compounds / pharmacology
  • Oxidative Stress / drug effects
  • Phosphorylation / drug effects
  • Rats
  • Rats, Wistar
  • Signal Transduction / drug effects

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Organometallic Compounds
  • Glycogen Synthase Kinase 3 beta
  • Gsk3b protein, rat
  • Casp3 protein, rat
  • Caspase 3
  • lead acetate
  • Carnitine